Biocartis
PrivateLast Round
Recap
Nov 22, 2023
Est. Valuation
$490.7M
Total Funding Raised
$344.48M
Momentum Score
25 /100
Company Overview
Biocartis is a molecular diagnostics company that provides a fully automated, sample-to-result, real-time PCR platform for oncology and infectious disease testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocartis Comps
Public and private peers based on sector, stage, and business model.
Biocartis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Recap | Nov 22, 2023 | ||||
| Debt | Nov 22, 2023 | ||||
| Private Placement | Nov 29, 2022 | ||||
| Private Placement | Jan 23, 2019 | ||||
| IPO Announced | Apr 27, 2015 | ||||
Private Placement | Sep 4, 2014 |
Key People
Founding team and executive leadership
Biocartis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UBS Group AG | IPO |
| Korys | Series C, Series D |
| KBC Group N.V. | Debt |
| Advent Venture Partners | Series A, Series B |
| KBC Securities | Private Placement |
| Aescap | Series B |
| PMV Tina Fund | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Developing a rapid breast cancer gene signature test with Medical College of Wisconsin.
- Mar 24, 2026
Partnering with Medical College of Wisconsin on breast cancer test development.
Biocartis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biocartis's valuation, stock price, and market status.
